Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-the-Market Under Nasdaq Rules finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million ... pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Dermata Therapeutics Announces Exercise of Warrants for $2.66 Million in Gross Proceeds Priced At-th pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.
- DMT310 Phase 3 Spongilla Treatment of Acne Research (STAR-1) clinical trial enrollment remains on track Dermata continues discussions with potential botulinum toxin partners for DMT410 Received issuance of Japanese patent for DMT410 for the treatment of hyperhidrosis -SAN DIEGO, CA / ACCESSWIRE / May 15, 202.
Dermata Therapeutics Provides Corporate Update and Reports First Quarter ... pr-inside.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pr-inside.com Daily Mail and Mail on Sunday newspapers.
Dermata Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Dermata Therapeutics : Provides Corporate Update and Reports First Quarter 2024 Financial Results - Form 8-K marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Dermata Therapeutics, Inc. (NASDAQ:DRMAW – Get Free Report) saw a large increase in short interest in the month of April. As of April 15th, there was short interest totalling 11,000 shares, an increase of 15.8% from the March 31st total of 9,500 shares. Based on an average daily trading volume, of 5,100 shares, the short-interest […]
Presenting on the Emerging Growth Conference 69 Day 2 on April 4 Register Now forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.
Dermata Therapeutics, Inc. (NASDAQ:DRMAW – Get Free Report) was the recipient of a significant growth in short interest in March. As of March 15th, there was short interest totalling 12,600 shares, a growth of 20.0% from the February 29th total of 10,500 shares. Based on an average daily volume of 5,700 shares, the days-to-cover ratio […]